Tag Archive for: Confo Therapeutics

partnership

Confo Therapeutics and Lilly partner to advance CFTX-1554

Drug developer Confo Therapeutics and Eli Lilly & Company have inked a worldwide licensing agreement to co develop Confo’s neurophatic pain candidate CFTX-1554.

Read more